Publisher
Springer Berlin Heidelberg
Reference22 articles.
1. Butwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutsch DG, Creasman WT, Flowers JL, (1986) Immunhistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Research 46: 5419–5425
2. Chambers JT, MacLusky N, Eisenfield A, Kohorn E, Lawrence R, Schwartz PE (1988) Estrogen and progestin receptor levels as prognosticator for survival in endometrial cancer. Gynecologic Oncology 31: 65–77
3. Ehrlich CE, Young PCM, Cleary RE (1981) Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria. Am J Obstet Gynecol 141: 539–546
4. Gambrell RD, Bagnell CA, Greenblatt RB (1983) Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: Review. Am. J. Obstet. Gynecol. 146: 696–707
5. Hähnel R, Martin JD, Masters AM, Ratajczak T, Twaddle E (1979) Estrogen receptors and blood hormone levels in endometrial carcinoma. Gynecologic Oncology 8: 209–225